Systematic Review
Frontiers in Fungal Biology ·
Volume 7 - 2026 | https://doi.org/10.3389/ffunb.2026.1853358
Global trends, translational gaps, and emerging research directions in Pleurotus spp. bioactivity research: a 25-year scientometric analysis
- Kevin Smith P. Cabuhat1,2
- Jamil Allen G. Fortaleza2,3*corresponding author
- Johnalie N. Cabalbag2
- Christian Joseph N. Ong2
- Jowi Tsidkenu Pili Cruz2
- Nicole Rajah C. del Rosario1
- Mary Ylane S. Lee4
- Jose Jurel M. Nuevo5
- Joel G. Matamis6
- Jose Edwardo R. Mamaat7
- Amelda C. Libres8
- Rich Milton R. Dulay2,9
- 1Basic Education Department, La Consolacion University Philippines, Malolos, Bulacan, Philippines
- 2Department of Biology, College of Science, De La Salle University, Manila, Philippines
- 3National University, Sampaloc, Manila, Philippines
- 4Department of Biology, Bulacan State University, Malolos, Bulacan, Philippines
- 5College of Medical Laboratory Science, Our Lady of Fatima University, Valenzuela, Philippines
- 6School of Medical Laboratory Sciences, St. Dominic College of Asia, Cavite, Philippines
- 7Department of Medical Technology, Far Eastern University, Manila, Philippines
- 8College of Medical Laboratory Science, Liceo de Cagayan University, Cagayan de Oro, Philippines
- 9Center for Tropical Mushroom Research and Development, Central Luzon State University, Science City of Muñoz, Nueva Ecija, Philippines
Abstract
Pleurotus spp. have attracted significant scientific interest for their diverse bioactive compounds and broad pharmacological potential. Despite the rapid growth of the literature, a comprehensive scientometric synthesis of this research landscape remains limited. This study used a systematic scientometric approach to analyze global research trends in Pleurotus bioactivity from 2000 to 2025. Key analyses included publication productivity, citation dynamics, co-authorship and country-level collaboration networks, keyword co-occurrence mapping, and thematic evolution. The results reveal relatively stable publication output accompanied by a marked increase in citation impact after 2012, indicating growing intellectual consolidation and global recognition of the field. China and India dominate research productivity, whereas citation influence is more widely distributed, highlighting disparities between output and impact. Thematic evolution shows a shift from early studies on cultivation and compositional profiling toward advanced research in molecular bioactivity, gut microbiota modulation, enzymatic biotechnology, and circular bioeconomy applications. Emerging directions include precision nutraceutical development, optimization of extraction and fermentation processes, and agro-industrial waste valorization. Despite increasing interdisciplinary integration and strong preclinical evidence, collaboration networks remain partially fragmented, and translation into clinical and industrial applications remains limited. These findings indicate that while research on Pleurotus has reached a stage of disciplinary maturity, significant gaps persist in standardization, clinical validation, and scalability. Addressing these challenges will require integrative omics approaches, strengthened global collaboration, and translational frameworks to bridge the gap between laboratory discoveries and real-world applications.
Keywords
1 Introduction
Pleurotus spp., commonly referred to as oyster mushrooms, represent a taxonomically diverse and ecologically adaptable genus of basidiomycete fungi widely distributed across tropical and subtropical ecosystems, where they play a critical role in lignocellulosic decomposition and nutrient cycling (Phonemany et al., 2021; Febnteh et al., 2025; Raman et al., 2021). Comprising approximately 208 recognized species, the genus exhibits substantial genetic, morphological, and ecological heterogeneity, indicating its evolutionary adaptability and broad environmental niche (Flores et al., 2023). Beyond their ecological significance, Pleurotus species have emerged as one of the most economically important cultivated mushrooms globally, accounting for nearly 25% of total mushroom production. This widespread cultivation underscores their dual importance as both a food resource and a biotechnological platform, particularly in regions across Asia, Europe, and North America (Raman et al., 2021). In parallel, their enzymatic machinery enables applications in lignocellulosic degradation, waste valorization, and environmental bioremediation, positioning Pleurotus as a key organism at the intersection of sustainable biotechnology and circular bioeconomy systems (Gregori et al., 2007).
The increasing scientific attention toward Pleurotus spp. is primarily driven by their extensive repertoire of bioactive compounds, including polysaccharides, phenolics, and secondary metabolites with demonstrated pharmacological properties. These compounds exhibit a broad spectrum of biological activities, such as antioxidant, anti-inflammatory, antimicrobial, and anticancer effects, thereby establishing Pleurotus as a promising candidate for nutraceutical development and therapeutic innovation (Mazumder et al., 2025). Accumulating evidence further highlights their role in mitigating chronic metabolic disorders, including diabetes, obesity, cardiovascular diseases, and gastrointestinal dysfunction, reinforcing their relevance within functional food and preventive medicine frameworks (Ajanaku et al., 2022; Zhang et al., 2020). Moreover, emerging studies indicate that Pleurotus-derived bioactives may influence neuroprotective pathways through modulation of oxidative stress and inflammatory signaling, suggesting potential applications in neurodegenerative disease management, including Alzheimer’s disease (Zhang et al., 2020). Collectively, these findings reflect a progressive shift from nutritional characterization toward mechanistic and translational research domains.
Despite the rapid expansion of literature, the intellectual structure, thematic evolution, and translational trajectory of Pleurotus research remain insufficiently integrated. Existing studies often address bioactivity, biotechnology, or pharmacological potential in isolation, limiting a comprehensive understanding of how these domains converge to shape the field’s development. Scientometric analysis offers a robust quantitative approach to address this gap by systematically mapping publication outputs, citation networks, collaborative structures, and thematic clusters over time. Beyond descriptive metrics, advanced bibliometric and network-based analyses enable the identification of emerging research frontiers, knowledge gaps, and structural imbalances within scientific ecosystems (Konur, 2020; Chen et al., 2025; Obajemu et al., 2012). When coupled with thematic interpretation, these approaches provide critical insights into how research domains evolve from foundational discovery toward applied and translational outcomes (Aksenova and Tarkhov, 2023).
In this context, the present study provides a comprehensive and integrative scientometric assessment of global research on the bioactivity and pharmacological potential of Pleurotus spp. over the past 25 years (2000-2025). Specifically, this study aims to (i) map the intellectual and collaborative structure of the field through publication, citation, and network analyses, (ii) characterize the thematic evolution and emerging research frontiers, and (iii) critically evaluate the alignment between research productivity and translational progression toward clinical, industrial, and sustainability applications.
2 Methodology
2.1 Data source and search strategy
A bibliometric analysis was performed to assess global research trends concerning the bioactivity and pharmacological potential of Pleurotus species. The Scopus database was chosen due to its comprehensive coverage of peer-reviewed biomedical and interdisciplinary literature. The search was limited to English-language journal articles published from 2000 to 2025. The search strategy incorporated species-specific terms (such as Pleurotus ostreatus, P. eryngii, P. pulmonarius, P. sajor-caju, P. florida, and P. citrinopileatus) in combination with keywords related to bioactivity and pharmacology. The complete search query used in Scopus was as follows:
TITLE-ABS-KEY (Pleurotus W/2 (species OR spp.) OR “Pleurotus ostreatus” OR “Pleurotus eryngii” OR “Pleurotus pulmonarius” OR “Pleurotus sajor-caju” OR “Pleurotus florida” OR “Pleurotus citrinopileatus”) AND TITLE-ABS-KEY (“bioactiv” OR “pharmacological activity” OR “biomedical application” OR “therapeutic potential” OR “in vitro” OR “in vivo” OR “mechanism of action”) AND PUBYEAR > 1999 AND PUBYEAR < 2026 AND (LIMIT-TO (SRCTYPE, “j”)) AND (LIMIT-TO (PUBSTAGE, “final”)) AND (LIMIT-TO (DOCTYPE, “ar”)) AND (LIMIT-TO (LANGUAGE, “English”)).
2.2 Screening and eligibility criteria
The analysis included only final journal articles published in English. Non-primary literature, such as conference papers, editorials, reviews, book chapters, notes, and other forms of gray literature, was excluded. Studies unrelated to the bioactivity, pharmacological properties, therapeutic applications, or mechanisms of action of Pleurotus species were also excluded to enhance dataset relevance and analytical precision. Figure 1 provides an overview of the study workflow, encompassing data retrieval, screening, eligibility assessment, and bibliometric analysis.

2.3 Bibliometric analysis framework
The bibliometric analysis followed the framework established by Donthu et al. (2021), integrating performance analysis and science mapping to assess the development of research on Pleurotus spp. bioactivity. Performance analysis evaluated research productivity and scientific impact across publications, countries, journals, authors, institutions, and cited documents. Annual scientific production and cumulative growth trends were analyzed to characterize the field’s temporal evolution. Citation-based indicators, including total publications (TP), total citations (TC), average citations per publication (ACP), and h-index, were used to measure scholarly influence. Country contributions were determined by corresponding author affiliations, and international collaboration was assessed using Single Country Publications (SCP) and Multiple Country Publications (MCP). The analysis identified the most productive journals, influential authors, institutions, countries, and highly cited documents to establish the field’s intellectual foundations and scientific impact.
2.4 Science mapping and network visualization
The dataset was analyzed using Biblioshiny (Bibliometrix R package) and VOSviewer version 1.6.20 (Centre for Science and Technology Studies [CWTS], Leiden University, Netherlands). Biblioshiny facilitated the assessment of annual scientific production, citation patterns, leading authors, institutional productivity, source journals, trend topics, thematic maps, and thematic evolution. Science mapping was conducted using VOSviewer to examine the social and conceptual structures of the research domain, following approaches commonly used in recent bibliometric studies (Akin et al., 2025). Co-authorship networks were constructed to evaluate collaboration patterns among authors, institutions, and countries. Keyword co-occurrence analysis of author keywords identified major thematic areas and their interrelationships within the literature. Network, overlay, and density visualizations were generated to reveal collaboration clusters, thematic structures, and emerging research directions. Clustering functions in VOSviewer grouped closely related authors, institutions, countries, and keywords into distinct collaborative and thematic clusters. In the resulting maps, node size indicated frequency of occurrence or productivity, link thickness represented the strength of relationships, and colors denoted cluster membership or temporal characteristics in overlay visualizations.
3 Results
3.1 Annual number of publications and cumulative growth curve
The bibliometric analysis demonstrates a dynamic yet progressively stabilizing trajectory in Pleurotus spp. bioactivity research, characterized by a divergence between publication output and citation impact. As illustrated in Figure 2, the annual number of publications shows a steady increase from the early 2000s, followed by a relatively stable output in recent years, indicating sustained research activity rather than exponential growth. In contrast, total citations per year (TCpY) exhibit a pronounced surge beginning around 2012, reflecting delayed recognition and increasing scholarly impact of earlier foundational studies. The cumulative growth curve further delineates this progression, with an initial exploratory phase (2000–2010) marked by gradual accumulation of publications, transitioning into a rapid expansion phase (2011–2020) driven by intensified research activity and collaborative efforts, and ultimately approaching a plateau in recent years. This plateau suggests a maturation of the field, where knowledge production stabilizes while impact continues to consolidate.

3.2 Leading and collaborating countries
The global landscape of Pleurotus research exhibits notable geographic variation, reflecting differences in productivity and collaboration. Mapping national contributions clarifies how domestic research strength and international partnerships shape the field’s development. This analysis identifies leading countries and emerging hubs over a 25-year period (Figure 3). China (n=230) and India (n=211) dominate, reflecting highly active scientific communities. The United States (n=84) and Italy (n=81) contribute significantly, while emerging hubs such as Brazil (n=79), Mexico (n=61), Egypt (n=44), and Nigeria (n=37) illustrate growing global engagement. These collaborations show how the field has grown through a mix of local expertise and international partnerships. Further insight into collaboration patterns is provided by a corresponding authorship analysis that distinguishes between Single Country Publications (SCP) and Multiple Country Publications (MCP). The results indicate that leading contributors such as China and India exhibit a predominance of SCP, suggesting strong domestic research capacity and well-established internal networks that sustain high publication output independently. In contrast, countries such as the United States, Italy, and Brazil demonstrate a relatively higher proportion of MCP, reflecting greater engagement in international collaborations and cross-border knowledge exchange.

3.3 Most Relevant Sources and cited documents
The bibliometric analysis reveals a structurally diverse yet hierarchically organized publication landscape in Pleurotus spp. bioactivity research, where productivity and citation impact are distributed unevenly across journals and seminal studies. As shown in Table 1, the International Journal of Medicinal Mushrooms ranks first in total publications (TP = 71), underscoring its role as a specialized outlet for mushroom-focused research. However, its comparatively lower CiteScore (2.9) and average citations per publication (ACP = 18.99) suggest that while it serves as a primary dissemination platform, its global citation influence is relatively limited. In contrast, broader, high-impact journals such as Food Chemistry (CiteScore = 18.3; ACP = 63.52) and Carbohydrate Polymers (CiteScore = 24.0; ACP = 56.64) exhibit significantly higher citation performance despite lower publication counts, indicating that studies published in these venues achieve greater visibility and scientific impact. This pattern highlights a dual publication dynamic in the field: specialized journals sustain research volume, whereas interdisciplinary journals amplify research influence. Similarly, the strong citation metrics of the International Journal of Biological Macromolecules (TC = 1,495; ACP = 39.34) and Food and Function (ACP = 35.06) reflect the increasing research emphasis on polysaccharides, macromolecular bioactives, and functional food applications of Pleurotus spp., signaling a shift toward biochemical and nutraceutical-oriented investigations.
Table 1. Top 10 most relevant sources publishing Pleurotus spp.
| Rank | Journal title | CiteScore2024 | Publisher | TP | TC | ACP | h-index |
|---|---|---|---|---|---|---|---|
| 1st | International Journal of Medicinal Mushrooms | 2.9 | Begell House | 71 | 1,348 | 18.99 | 20 |
| 2nd | International Journal of Biological Macromolecules | 10.3 | Elsevier | 38 | 1,495 | 39.34 | 21 |
| 3rd | Food Chemistry | 18.3 | Elsevier | 33 | 2,096 | 63.52 | 22 |
| 4th | Molecules | 8.6 | Multidisciplinary Digital Publishing Institute (MDPI) | 22 | 743 | 33.77 | 15 |
| 5th | Foods | 8.7 | Multidisciplinary Digital Publishing Institute (MDPI) | 19 | 391 | 20.58 | 10 |
| 6th | Food and Function | 10.5 | Royal Society of Chemistry | 16 | 561 | 35.06 | 11 |
| 7th | LWT | 13.6 | Elsevier | 15 | 497 | 33.13 | 13 |
| 8th | Journal of Agricultural and Food Chemistry | 9.3 | American Chemical Society | 14 | 558 | 39.86 | 11 |
| 9th | Animal Feed Science and Technology | 6.0 | Elsevier | 11 | 429 | 39.00 | 8 |
| 9th | Carbohydrate Polymers | 24.0 | Elsevier | 11 | 623 | 56.64 | 11 |
| 9th | PLOS One | 5.4 | Public Library of Science | 11 | 306 | 27.82 | 9 |
| 10th | World Journal of Microbiology and Biotechnology | 6.7 | Springer Nature | 9 | 166 | 18.44 | 6 |
| 10th | Journal of the Science of Food and Agriculture | 7.9 | John Wiley & Sons | 9 | 211 | 23.44 | 8 |
| 10th | Journal of Fungi | 8.4 | Multidisciplinary Digital Publishing Institute (MDPI) | 9 | 116 | 12.89 | 7 |
| 10th | Chemistry and Biodiversity | 3.5 | John Wiley & Sons | 9 | 65 | 7.22 | 4 |
* ACP, average citations per paper; TC, total citations; TP, total publications. Rank was based on TP.
This thematic and impact-driven stratification is further reinforced by the highly cited documents presented in Table 2, which collectively define the intellectual foundation and evolution of the field. Foundational reviews such as Lindequist et al. (2005) (910 citations) and Sullivan et al. (2006) (242 citations) establish the pharmacological and therapeutic relevance of medicinal mushrooms, serving as key conceptual anchors for subsequent research. Meanwhile, studies such as Reis et al. (2012) and Jayakumar et al. (2009) emphasize antioxidant activity and phenolic composition, reflecting the early dominance of functional and biochemical characterization. More recent highly cited works, including Bellettini et al. (2019) and Ruwizhi and Aderibigbe (2020), indicate a transition toward understanding cultivation factors, bioactive compound optimization, and molecular-level mechanisms, aligning with the growing interest in translational and applied research. Notably, the prominence of studies on immunomodulatory (Sarangi et al., 2006) and enzymatic/biodegradation functions (Palmieri et al., 2005) further demonstrates the expanding scope of Pleurotus research beyond nutrition into pharmaceutical and environmental applications.
Table 2. Highly cited studies shaping the development and evolution of Pleurotus spp. bioactivity research over 25 years.
| Authors | Title | Year | Source title | Cited by | DOI |
|---|---|---|---|---|---|
| Lindequist et al. (2005) | The pharmacological potential of mushrooms | 2005 | Evidence-based Complementary and Alternative Medicine | 910 | 10.1093/ecam/neh107 |
| Bellettini et al. (2019) | Factors affecting mushroom Pleurotus spp. | 2019 | Saudi Journal of Biological Sciences | 427 | 10.1016/j.sjbs.2016.12.005 |
| Ruwizhi and Aderibigbe (2020) | Cinnamic acid derivatives and their biological efficacy | 2020 | International Journal of Molecular Sciences | 415 | 10.3390/ijms21165712 |
| Rathore et al. (2017) | Mushroom nutraceuticals for improved nutrition and better human health: A review | 2017 | PharmaNutrition | 401 | 10.1016/j.phanu.2017.02.001 |
| Reis et al. (2012) | Antioxidant properties and phenolic profile of the most widely appreciated cultivated mushrooms: A comparative study between in vivo and in vitro samples | 2012 | Food and Chemical Toxicology | 311 | 10.1016/j.fct.2012.02.013 |
| Sarangi et al. (2006) | Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans | 2006 | International Immunopharmacology | 262 | 10.1016/j.intimp.2006.04.002 |
| Palmieri et al. (2005) | Remazol Brilliant Blue R decolorization by the fungus Pleurotus ostreatus and its oxidative enzymatic system | 2005 | Enzyme and Microbial Technology | 248 | 10.1016/j.enzmictec.2004.03.026 |
| Sullivan et al. (2006) | Medicinal mushrooms and cancer therapy: Translating a traditional practice into Western medicine | 2006 | Perspectives in Biology and Medicine | 242 | 10.1353/pbm.2006.0034 |
| Raman et al. (2021) | Cultivation and Nutritional Value of Prominent Pleurotus spp.: An Overview | 2021 | Mycobiology | 229 | 10.1080/12298093.2020.1835142 |
| Cohen et al. (2014) | Chemical composition and nutritional and medicinal value of fruit bodies and submerged cultured mycelia of culinary-medicinal higher basidiomycetes mushrooms | 2014 | International Journal of Medicinal Mushrooms | 223 | 10.1615/IntJMedMushr.v16.i3.80 |
| Jayakumar et al. (2009) | In-vitro antioxidant activities of an ethanolic extract of the oyster mushroom, Pleurotus ostreatus | 2009 | Innovative Food Science and Emerging Technologies | 223 | 10.1016/j.ifset.2008.07.002 |
3.4 Most productive authors and co-authorship networks
Author productivity and co-authorship patterns reveal a highly interconnected yet regionally clustered research landscape in Pleurotus spp. studies. As shown in Table 3, Hu Qiu Hui (TP = 26; TC = 1,135; ACP = 43.65) emerges as the most productive and influential author, followed by Ma Gao Xing and Zervakis Georgios I., reflecting strong contributions from institutions in China and Europe. Notably, authors affiliated with Nanjing University and related Chinese institutions dominate in terms of publication output, while European researchers, particularly from Greece and Portugal, demonstrate competitive citation impact, as evidenced by high ACP values (e.g., Ferreira and Barros with ACP = 88.22). This indicates a dual pattern where Asian institutions lead in productivity, whereas European groups contribute highly cited and potentially more specialized or review-oriented work. Further insight into international collaboration patterns is illustrated by the country co-authorship network (Figure 4A), which identifies major collaboration clusters among countries. The temporal evolution of these collaborations is shown in the overlay visualization (Figure 4B), while the global collaboration map (Figure 4C) highlights the geographic distribution and strength of international research partnerships.
Table 3. Top 10 most relevant authors publishing Pleurotus spp.
| Rank | Author | Affiliation | TP | TC | ACP | h-index |
|---|---|---|---|---|---|---|
| 1st | Hu, Qiu Hui | Nanjing University | 26 | 1,135 | 43.65 | 17 |
| 2nd | Ma, Gao Xing | Nanjing University | 17 | 765 | 45.00 | 10 |
| 2nd | Zervakis, Georgios I. | Agricultural University of Athens | 17 | 556 | 32.71 | 11 |
| 3rd | Koutrotsios, Georgios | Agricultural University of Athens | 14 | 520 | 37.14 | 10 |
| 3rd | Zhao, Li Yan | Nanjing Agricultural University | 14 | 685 | 48.93 | 12 |
| 4th | Yang, Wen Jian | Nanjing University | 13 | 755 | 58.08 | 11 |
| 5th | Vamanu, Emanuel | Universitatea de Stiinte Agronomice si Medicina Veterinaria din Bucuresti | 12 | 281 | 23.42 | 10 |
| 6th | Abdullah, Noorlidah | Universiti Malaya | 11 | 334 | 30.36 | 8 |
| 6th | Kyriacou, Adamantini | Harokopio University of Athens | 11 | 191 | 17.36 | 7 |
| 6th | Martinez, Angel T. | Centro de Investigaciones Biologicas Margarita Salas | 11 | 581 | 52.82 | 10 |
| 7th | Cone, John W. | Wageningen University & Research | 10 | 373 | 37.30 | 8 |
| Maiti, Tapas K. | Indian Institute of Technology | 10 | 519 | 51.90 | 10 | |
| 8th | Barros, Lillian | Instituto Politecnico de Braganca | 9 | 794 | 88.22 | 9 |
| Ferreira, Isabel C.F.R. | Instituto Politecnico de Braganca | 9 | 794 | 88.22 | 9 | |
| Kerezoudi, Evangelia N. | Orebro Universitet | 9 | 160 | 17.78 | 6 | |
| Mitsou, Evdokia | Harokopio University of Athens | 9 | 186 | 20.67 | 7 | |
| Pei, Fei | Nanjing University | 9 | 567 | 63.00 | 9 | |
| Pletsa, Vasiliki | National Hellenic Research Foundation | 9 | 146 | 16.22 | 6 | |
| Saxami, Georgia | Harokopio University of Athens | 9 | 151 | 16.78 | 7 | |
| 9th | Angelini, Paola | Universita degli Studi di Perugia | 8 | 202 | 25.25 | 7 |
| Hendriks, W.H. | Wageningen University & Research | 8 | 317 | 39.63 | 6 | |
| Iacomini, Marcello | Universidade Federal do Parana | 8 | 198 | 24.75 | 6 | |
| Jia, Le | Shandong Agricultural University | 8 | 405 | 50.63 | 7 | |
| Muszynska, Bozena | Jagiellonia University Medical College | 8 | 212 | 26.50 | 5 | |
| Xiao, Hang | University of Massachusetts Amherst | 8 | 395 | 49.38 | 7 | |
| 10th | Aguilar-Marcelino, Liliana | Instituto Nacional de Investigaciones Forestales, Agricolas y Pecuarias | 7 | 57 | 8.14 | 4 |
| Heredia, Ana | Universitat Politecnica | 7 | 133 | 19.00 | 5 | |
| Isikhuemhen, Omoanghe S. | North Carolina Agricultural and Technical State University | 7 | 54 | 7.71 | 4 | |
| Ma, Ning | Nanjing University | 7 | 456 | 65.14 | 6 | |
| Siwulski, Marek | Uniwersystet Przyrodniczy w Poznaniu | 7 | 106 | 15.14 | 5 | |
| Venanzoni, Roberto | Universita degli Studi di Perugia | 7 | 163 | 23.29 | 6 | |
| 10th | Zhang, Jian Jun | Shandong Agricultural University | 7 | 385 | 55.00 | 6 |
* ACP, average citations per paper; TC, total citations; TP, total publications. Rank was based on TP.

3.5 Co-occurrence network of Pleurotus research
Keyword co-occurrence analysis reveals a well-structured and thematically diverse research landscape in Pleurotus spp. studies, reflecting the field’s evolution from fundamental biology to multidisciplinary applications. As shown in Figure 5, the network visualization (a) identifies five major clusters, while the overlay visualization (b) highlights the temporal progression of research themes, indicating a shift from foundational studies toward more application-driven and mechanistic investigations. The red cluster is centered on core species such as P. ostreatus, emphasizing nutritional composition and phenolic content, thereby establishing the foundational knowledge of mushroom bioactivity. Closely linked, the blue cluster reflects therapeutic and medicinal applications, including antioxidant, antimicrobial, and cytotoxic activities, suggesting a strong translational bridge between food science and pharmacology. The green cluster further refines this direction by focusing on the isolation and characterization of bioactive compounds, underscoring the growing importance of molecular-level investigations in identifying functional metabolites. Meanwhile, the purple cluster highlights structural biochemistry, particularly polysaccharides such as β-glucans, and their roles in immune modulation and gut microbiota regulation, indicating an increasing focus on gut health and immunonutrition. In contrast, the orange cluster represents industrial biotechnology and mycoremediation, emphasizing enzymatic degradation, lignocellulosic processing, and environmental applications, thereby expanding the relevance of Pleurotus beyond health into sustainability domains. These thematic domains and their defining characteristics are summarized in Table 4, which further delineates the focus and notable features of each cluster.

Table 4. Thematic clusters in Pleurotus spp. bioactivity research. .
| Cluster color | Theme | Focus | Notable features |
|---|---|---|---|
| Red | Core Species & Biological Activity | Centers on P. ostreatus, examining nutritional and chemical profiles, including phenolic compounds. | Emphasizes health-promoting properties of primary cultivars; highlights nutraceutical potential of staple edible mushrooms. |
| Blue | Therapeutic & Medicinal Applications | Bridges food and medicine, exploring antimicrobial, antioxidant, and cytotoxic activities. | Highlights therapeutic applications and clinical relevance; positions species for pharmacological and medicinal studies. |
| Green | Bioactive Compounds & Supplements | Focuses on isolating and characterizing bioactive molecules. | Defines compounds responsible for health benefits; links molecular identification to nutraceutical applications. |
| Purple | Structural Biochemistry & Gut Health | Investigates mushroom polysaccharides like β-glucans, their chemical structure and functional role. | Connects compounds to immune modulation and gut microbiota; emphasizes digestive and prebiotic health effects. |
| Orange | Industrial Biotechnology & Mycoremediation | Studies enzymatic degradation of lignin and other materials. | Demonstrates industrial and environmental potential in waste management and bioenergy; focuses on fermentation and bioremediation. |
Analysis at the species level indicates that Pleurotus ostreatus is the most extensively studied taxon within the genus. This species is a focal point of research on nutritional composition, antioxidant activity, polysaccharides, immunomodulation, cultivation, and environmental biotechnology, underscoring its significance as both a commercially cultivated mushroom and a model organism in Pleurotus studies. Other frequently examined species include P. eryngii, P. pulmonarius, P. sajor-caju, P. florida, and P. citrinopileatus, which have been studied for their bioactive compounds, therapeutic potential, and industrial applications. However, the current literature reveals a pronounced taxonomic focus on a limited number of commercially cultivated species, indicating that the bioactive and biotechnological potential of many lesser-known Pleurotus taxa remains underexplored.
3.6 Emerging frontiers in Pleurotus spp. bioactivity research
Emerging frontiers in Pleurotus spp. bioactivity research reflects a pronounced transition from descriptive and antioxidant-centered investigations toward technologically integrated, application-driven, and sustainability-oriented frameworks. As illustrated in Figure 6, contemporary research is increasingly characterized by the convergence of bioactivity studies, industrial biotechnology, and environmental sustainability, indicating a shift toward systems-level approaches aligned with global bioeconomy priorities. While early investigations predominantly focused on P. ostreatus and its nutritional and antioxidant properties, recent studies have expanded both taxonomic and mechanistic scope, incorporating underexplored species such as P. citrinopileatus and P. florida, alongside more targeted evaluations of molecular pathways underlying bioactivity. This transition is further contextualized through the temporal framework presented in Table 5, which reveals not only chronological progression but also a functional transformation of the field. During the foundational era (2000-2010), research primarily centered on optimizing cultivation strategies, particularly solid-state fermentation on agro-wastes, and establishing baseline enzymatic and biochemical profiles, with applications largely confined to nutritional use and preliminary antimicrobial and antitumor assessments. In the diversification era (2011–2019), the field underwent significant methodological and application-oriented expansion, driven by the adoption of green extraction technologies and submerged fermentation systems, which enabled more efficient production and characterization of bioactive compounds. This period also marked a transition toward targeted therapeutic applications, including immunomodulatory, anti-diabetic, and anti-inflammatory interventions, alongside the early emergence of cosmeceutical and peptide-based products.

Table 5. Evolution of Pleurotus bioactivity research (2000-2025).
| Period | Technological and methodological advances | Industrial applications | Sustainability initiatives |
|---|---|---|---|
| 2000-2010 (Foundational Era) | Basic solid-state fermentation (SSF) on agro-wastes (straw, husks); optimization of cultivation parameters and spawn production; early enzyme characterization (laccase, peroxidase) | Primarily used as a nutritious food source; early nutraceutical exploration (polysaccharide extracts); crude extracts studied for antimicrobial and antitumor activity | Limited agro-waste utilization; initial reuse of spent mushroom substrate (SMS) as animal feed |
| 2011–2019 (Era of Diversification) | Advanced SSF targeting enzyme production; green extraction technologies (UAE, MAE); submerged fermentation (SmF) for mycelial biomass and bioactive compound production | Targeted health applications including immunomodulatory, anti-diabetic, and anti-inflammatory products; early cosmetic formulations; bioactive peptide production from protein hydrolysates | Valorization of diverse agro-industrial wastes (coffee husks, oil cakes); SMS applied in mycoremediation and as biofertilizer |
| 2020-2025 (Circular Bioeconomy Era) | AI-assisted process optimization (ANN-GA); synergistic extraction technologies (plasma-ultrasound); biorefinery integration; development of mycelium-based composites and nanoparticle platforms | Precision nutraceuticals for anti-aging and cognitive health; cosmeceuticals for anti-photoaging; active food packaging; functional biomaterials for tissue engineering and drug delivery | Integrated waste valorization systems: SMS used for biopesticides, animal feed, and substrate recycling; mycelium-based biocomposites and upcycling of complex agro-industrial wastes (brewer’s spent grain, MAP residues) |
The most recent phase, defined here as the circular bioeconomy era (2020-2025), represents a paradigm shift toward integrative and high-technology-driven research. Advances such as AI-assisted process optimization, biorefinery integration, and synergistic extraction technologies have enabled more precise and scalable production of bioactive compounds and functional biomaterials. Concurrently, applications have evolved toward high-value outputs, including precision nutraceuticals, active food packaging systems, and biomaterials for tissue engineering and drug delivery. Sustainability has likewise transitioned from a peripheral consideration to a central research driver, with integrated waste valorization systems, mycelium-based composites, and the upcycling of complex agro-industrial residues reflecting a circular systems approach. Collectively, these developments indicate that Pleurotus research is increasingly positioned within an interconnected framework that links molecular bioactivity, industrial scalability, and environmental sustainability, although the parallel progression of these domains suggests that full integration remains incomplete and warrants further interdisciplinary consolidation.
4 Discussion
Over the past 25 years (2000-2025), Pleurotus bioactivity research has evolved from fragmented, descriptive investigations into a more structured and increasingly interdisciplinary field. This progression is reflected in the divergence between publication output and citation impact (Figure 2), where relatively stable publication trends contrast with a marked increase in citations after 2012, suggesting a shift toward greater scientific influence and consolidation of knowledge. Early studies were largely exploratory, focusing on taxonomic classification, cultivation practices, and compositional profiling, which established Pleurotus as both a nutritionally valuable and biologically relevant genus (Lindequist et al., 2005; Sullivan et al., 2006). However, the transition toward more mechanistic and application-driven research indicates that the field has moved beyond descriptive characterization toward a more mature phase aligned with contemporary natural products research.
The geographic distribution of research highlights a dual structure in global knowledge production. While countries such as China and India dominate in publication output (Figure 3), citation influence appears more globally distributed, with European and North American studies contributing disproportionately to conceptual and highly cited work (Sarangi et al., 2006; Cohen et al., 2014). This divergence reflects differences in research infrastructure, funding capacity, and publication strategies, where high-output regions tend to prioritize experimental productivity, while others contribute integrative and methodological advancements. Importantly, this pattern suggests that scientific impact in Pleurotus research is shaped not only by biological resource availability but also by institutional and collaborative dynamics.
Collaboration networks further reveal a structurally complex and partially fragmented research landscape. Co-authorship patterns (Figure 4) demonstrate strong regional clustering alongside emerging international linkages, indicating that while collaboration has increased, it remains unevenly distributed. Research communities continue to be organized around specific thematic domains, including polysaccharide chemistry, enzymology, pharmacological bioactivity, and environmental biotechnology (Palmieri et al., 2005; Reis et al., 2012). Although bridging authors and institutions are beginning to connect these clusters, the persistence of partially isolated sub-networks suggests that integration between mechanistic laboratory research and clinically or industrially oriented applications remains limited. This structural fragmentation may contribute to the observed gap between scientific discovery and real-world implementation.
Thematic evolution analysis (Figure 5) provides further evidence of this transition, showing a clear shift from early descriptive studies toward molecular and mechanistic investigations. Initial research themes centered on protein composition, mineral content, and cultivation parameters have progressively evolved toward more complex topics such as oxidative stress regulation, immune modulation, and cellular signaling pathways (Lindequist et al., 2005; Bellettini et al., 2019; Ruwizhi and Aderibigbe, 2020). Despite this evolution, core themes, particularly polysaccharides, antioxidant activity, and immunomodulatory effects, remain central to the field (Rathore et al., 2017; Reis et al., 2012), reflecting both their therapeutic relevance and their methodological accessibility. At the same time, emerging areas such as environmental biotechnology and metabolic health research highlight the expanding role of Pleurotus spp. in addressing interconnected challenges in human health and environmental sustainability (Palmieri et al., 2005; Raman et al., 2021). This convergence aligns with a One Health perspective, although the continued separation of biomedical and environmental research domains suggests that full interdisciplinary integration has not yet been achieved.
Despite the strong growth and intellectual maturation of the field, a substantial translational gap persists between laboratory discoveries and real-world applications. Highly cited studies continue to emphasize foundational bioactivity, methodological development, and integrative reviews (Lindequist et al., 2005; Reis et al., 2012; Bellettini et al., 2019), whereas relatively few investigations progress toward clinical validation or large-scale industrial implementation (Cohen et al., 2014; Raman et al., 2021). This imbalance reflects persistent barriers, including limited pharmacokinetic data, lack of standardized extraction and characterization protocols, and challenges in scalability and regulatory alignment (Palmieri et al., 2005). As a result, citation impact often reflects academic visibility rather than direct societal or clinical relevance. Addressing these limitations will require stronger integration between experimental research, clinical validation, and industrial application, supported by interdisciplinary collaboration and translational research frameworks that bridge the gap between discovery and implementation.
4.1 Translational bottlenecks and future directions in Pleurotus research for human clinical application
Pleurotus species, rich in β-glucans, proteo-polysaccharides, and phenolic compounds, exhibit significant therapeutic potential, including immunomodulatory, antioxidant, and antitumor activities; however, translation into human clinical application remains constrained by interconnected scientific, technical, and systemic bottlenecks. As illustrated in Figure 7, variability in bioactive composition driven by species differences, cultivation conditions, and extraction techniques represents a primary limitation, complicating standardization, reproducibility, and the establishment of consistent therapeutic outcomes and dosing strategies (Khatua, 2025; Selvaananthi and Beulah Jerlin, 2024; Araújo et al., 2025). This variability is further exacerbated by taxonomic ambiguity, where phenotypic plasticity and genus-level classification obscure species-specific pharmacological profiles, necessitating molecular authentication tools such as ITS sequencing and multi-locus markers, alongside chemotaxonomic profiling (LC-MS, HPLC) to ensure biochemical consistency and mechanistic clarity (Li et al., 2022; Sharma et al., 2020; Zervakis, 2004; He et al., 2017; Li et al., 2017; Flores et al., 2023; Ćilerdžić and Galić, 2025; Acharya et al., 2017).

Pharmacokinetic limitations further hinder clinical translation, as human data on absorption, distribution, metabolism, and excretion remain scarce, and bioavailability is often unpredictable due to solubility and stability constraints of compounds such as β-glucans and ergothioneine (Araújo et al., 2025; Ioannidis, 2019; Stegemann et al., 2007; Zhang et al., 2024; de Oliveira et al., 2022). Reproducibility is similarly constrained by heterogeneous experimental designs, limited multi-center validation, and preclinical models that inadequately reflect human physiological complexity (Karp, 2018; Fell et al., 2022; Marshall et al., 2005; Yao and Kanellakis, 2020). Although emerging extraction approaches such as aqueous two-phase systems and enzyme-assisted extraction enhance recovery efficiency, the absence of standardized protocols continues to limit cross-study comparability (Yang et al., 2025; Xie et al., 2024; You et al., 2025).
Regulatory, economic, and societal factors further shape translational outcomes. Natural-product therapeutics require rigorous clinical validation and mechanistic evidence, yet fragmented funding, limited infrastructure, and unclear regulatory pathways delay development and commercialization (Letourneur et al., 2021; Balash et al., 2025; Kanwal et al., 2025; Lems et al., 2025; Araújo et al., 2025). Public perception and awareness also influence research prioritization and adoption, emphasizing the socio-scientific dimension of translation. Additionally, structural inequalities in global research limit participation from biodiversity-rich regions due to disparities in funding, infrastructure, and access to international networks, reinforcing a core–periphery knowledge structure (Valdez et al., 2024; Singh et al., 2025; Roch et al., 2025; Liu et al., 2017; He et al., 2020, He et al., 2021). Practices such as parachute science and tokenistic collaborations further marginalize local expertise, necessitating equitable partnerships, inclusive funding systems, and open science frameworks to foster global research integration (Koch et al., 2025; Doğan et al., 2023; Tolochko and Vadrot, 2021; Coombe et al., 2023; Bezuidenhout, 2025; Báldi and Palotás, 2021; Klincewicz and Esmaeil Zaei, 2025; Elkayam Cohen and Fluhr, 2024; Roberts et al., 2012).
Integrating Pleurotus research within a One Health framework introduces additional challenges, particularly in scaling environmental applications such as biodegradation and agro-industrial waste valorization from laboratory to field settings. Standardization of environmental endpoints, ecotoxicological validation, and long-term monitoring remain underdeveloped, while weak governance structures and limited interdisciplinary coordination hinder implementation (Lozada-Martinez et al., 2026; Faijue et al., 2024; Pumipuntu and Suwannarong, 2025; Abass et al., 2025; Utomo, 2026; Meisner et al., 2024; Nowbuth and Parmar, 2025; Garg et al., 2025). Similarly, industrial-scale deployment is constrained by low technological readiness levels (TRL 3-5), high operational costs, and insufficient policy support, despite strong potential in enzyme production, lignocellulosic bioconversion, and circular bioeconomy applications (Schein et al., 2026; Bonis et al., 2026; Mastranzo-Pérez et al., 2025; Ghafoor and Niazi, 2025; Ayuso et al., 2025; Morenikeji Abel et al., 2025; Silva et al., 2024).
Emerging integrative strategies provide viable pathways to overcome these barriers. Omics-based approaches and systems biology enable precise identification, monitoring, and mechanistic understanding of bioactive compounds (Patel et al., 2017; Govindaraj and Renganathan, 2017; Ashmore-Harris et al., 2024), while in silico pharmacokinetic modeling and non-invasive sampling techniques improve dose optimization and safety in clinical studies (Ashmore-Harris et al., 2024; Desai and Cristofoletti, 2025). Adaptive clinical trial designs and multi-laboratory validation frameworks can enhance reproducibility and translational relevance (Karp, 2018; Wang and Wang, 2024; Lippi et al., 2016), whereas coordinated governance, policy engagement, and community-based initiatives are essential to bridge research, industry, and societal adoption (Lozada-Martinez et al., 2026; Karakhanova et al., 2024; Delonge et al., 2020; Gómez-Jiménez et al., 2026).
4.2 Limitations of the study
Despite the comprehensive scope and analytical depth of this scientometric assessment, several methodological limitations must be acknowledged. First, the reliance on a single bibliographic database (Scopus) introduces inherent database bias, as publication coverage, indexing criteria, and journal inclusion policies differ across platforms. This may lead to the underrepresentation of relevant studies indexed in other databases such as Web of Science, PubMed, or regional repositories, particularly those originating from non-English-speaking regions where Pleurotus cultivation and application are highly prevalent. Additionally, citation-based indicators, while widely used as proxies for scientific impact, are subject to citation bias and may not accurately reflect translational relevance or real-world application. Highly cited studies often correspond to foundational or review articles, whereas applied research and community-based innovations may remain underrepresented despite their significant socioeconomic contributions.
Furthermore, the use of author keywords and indexed terms for co-occurrence and thematic analyses introduces limitations related to keyword normalization and semantic variability. Inconsistent terminology, broad descriptors such as Pleurotus spp., and variations in keyword assignment may reduce species-level resolution and obscure biochemical and pharmacological differences across taxa. This constraint is particularly relevant in a biologically diverse genus where functional properties vary substantially between species. Finally, although this study incorporates a translational perspective, the evaluation of clinical and industrial progression is inferred from publication trends rather than directly validated through clinical trial data, regulatory frameworks, or technology readiness assessments. Future studies integrating multi-database approaches, standardized keyword harmonization, and complementary systematic or qualitative methodologies may further enhance the robustness and translational relevance of scientometric analyses in Pleurotus research.
5 Conclusion
This scientometric analysis presents a comprehensive overview of global research trends concerning the bioactivity and pharmacological potential of Pleurotus species from 2000 to 2025. The results demonstrate a gradual shift in the field from primarily descriptive and nutrition-focused studies to research emphasizing molecular bioactivity, biotechnology, and sustainability applications. Research activity was predominantly concentrated in Asia, especially in China and India, whereas citation influence was more widely distributed across Europe and North America. Thematic analysis reveals increasing interest in functional foods, bioactive compounds, industrial biotechnology, and environmental applications. However, the majority of existing literature remains centered on preclinical and experimental studies, with relatively limited clinical validation and large-scale implementation. There are ongoing opportunities to enhance integration among biomedical, industrial, and sustainability-focused research domains. Advancing the field may require continued interdisciplinary collaboration, methodological standardization, and translational research. In summary, this study elucidates the development of Pleurotus bioactivity research over the past 25 years and identifies emerging themes and future research directions.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Footnotes
Edited by: Antonio Moretti, National Research Council (CNR), Italy
Reviewed by: Anupam Barh, ICAR-Directorate of Mushroom Research, India
Meleksen Akin, Iğdır Üniversitesi, Türkiye
Statements
- Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- Funding
The author(s) declared that financial support was not received for this work and/or its publication.
- Data availability
The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.
- Author contributions
KC: Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing. JF: Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review & editing. JC: Writing – original draft, Writing – review & editing. JC: Supervision, Writing – original draft, Writing – review & editing. Nd: Writing – original draft, Writing – review & editing. ML: Writing – original draft, Writing – review & editing. JN: Supervision, Writing – original draft, Writing – review & editing. JM: Supervision, Writing – original draft, Writing – review & editing. JRM: Supervision, Writing – original draft, Writing – review & editing. RD: Supervision, Writing – original draft, Writing – review & editing. CO: Writing – original draft, Writing – review & editing. AL: Supervision, Writing – original draft, Writing – review & editing.
References
- Abass K., Hinkston I., Yusuf H., Semerjian L. (2025). One health in Gulf Cooperation Council countries: A roadmap for integrated human–animal–environment health. J. Public Health (Germany), 1 – 26. doi: doi:10.1007/s10389-025-02621-y
- Acharya K., Khatua S., Ray S. (2017). Quality assessment and antioxidant study of Pleurotus djamor (Rumph. ex Fr.) Boedijn. J. Appl. Pharm. Sci 7, 105 – 110. doi: doi:10.7324/JAPS.2017.70614
- Ajanaku C. O., Ademosun O. T., Atohengbe P. O., Ajayi S. O., Obafemi Y. D., Owolabi O. A.. (2022). Functional bioactive compounds in ginger, turmeric, and garlic. Frontiers in Nutrition 9, 1012023.
- Akin M., Eyduran S. P., Mileševic J., Pavlovic S., Orahovac A., Vasconcelos M. W.. (2025). Nutritional composition and health benefits of peas-a bibliometric research. Front. Nutr 12, 1550142. doi: doi:10.3389/fnut.2025.1550142
- Aksenova E. I., Tarkhov K. Y. (2023). “ Scientometric analysis of the main thematic fields and keywords in the subject area «Public health, environmental and occupational health»,” in Problems of Social Hygiene, Public Health and History of Medicine 31 (S2), 1104 – 1108. doi: doi:10.32687/0869-866x-2023-31-s2-1104-1108
- Araújo P. L., Araújo E. D. S., Barreto E. M. D. A., Alves J. L. D. B., Souza K. M., Freire M. O. D. L.. (2025). Pleurotus mushrooms in nutrition and health: Clinical and preclinical insights for nutraceutical development. Compr. Rev. Food Sci. Food Saf. 24 (5), e70279. doi: doi:10.1111/1541-4337.70279
- Ashmore-Harris C., Antonopoulou E., Finney S. M., Vieira M. R., Hennessy M. G., Muench A.. (2024). Exploiting in silico modelling to enhance translation of liver cell therapies from bench to bedside. NPJ Regenerative Medicine 9 (1), 19. doi:. doi:10.1038/s41536-024-00361-3
- Ayuso P., Quizhpe J., Peñalver R., García-Pérez P., Nieto G. (2025). Green valorization strategies of Pleurotus ostreatus and its by-products: A critical review of emerging technologies and sustainable applications. Molecules 30, 4318. doi: doi:10.3390/molecules30214318
- Balash M., Boucetta H., He W. (2025). Factors affecting drug delivery system translation: A focus on advanced technologies, biological barriers, and regulatory challenges. Journal of Controlled Release 387, 114167. doi:. doi:10.1016/j.jconrel.2025.114167
- Báldi A., Palotás B. (2021). How to diminish the geographical bias in IPBES and related science ? Conservation Letters 14 (1), e12786.
- Bellettini M. B., Fiorda F. A., Maieves H. A., Teixeira G. L., Ávila S., Hornung P. S.. (2019). Factors affecting mushroom Pleurotus spp. Saudi. J. Biol. Sci 26, 633 – 646. doi: doi:10.1016/j.sjbs.2016.12.005
- Bezuidenhout L. (2025). Critically unpacking the concept of equity for open science. Soc. Epistemol, 1 – 18. doi: doi:10.1080/02691728.2025.2475460
- Bonis M. D., Rocchi L., Paolotti L., Sambo P., Zanin G., Nicoletto C. (2026). Vertical farming: A sustainable approach for Pleurotus spp. cultivation. Sustainability 18, 384. doi: doi:10.3390/su18010384
- Chen L. F., Bin J. F., Zhang Q., Li H., Chen W., Ge H. (2025). Hotspots and scientometrics in gallbladder cancer surgery research: a bibliometric and visualization analysis, (2014-2024). Front. Oncol 15, 1522992. doi: doi:10.3389/fonc.2025.1522992
- Ćilerdžić J., Galić M. (2025). “ Anti-inflammatory and anticancer activities of Pleurotus spp,” in Pleurotus: From Farm to Pharmacy (CRC Press), 132 – 142. doi: doi:10.1201/9781003527572-9
- Cohen N., Cohen J., Asatiani M. D., Varshney V. K., Yu H. T., Yang Y. C.. (2014). Chemical composition and nutritional and medicinal value of fruit bodies and submerged cultured mycelia of culinary-medicinal higher Basidiomycetes mushrooms. Int. J. Med. Mushrooms 16. doi: doi:10.1615/intjmedmushr.v16.i3.80
- Coombe C. M., Simbeni S., Neal A., Allen A. J., Gray C., Guzman J. R.. (2023). Building the foundation for equitable and inclusive research: Seed grant programs to facilitate development of diverse CBPR community-academic research partnerships. J. Clin. Transl. Sci 7, e2. doi: doi:10.1017/cts.2022.495
- Delonge M., Robbins T., Basche A. D., Haynes-Maslow L. (2020). The state of sustainable agriculture and agroecology research and impacts: A survey of U.S. scientists. J. Agric. Food Sys. Community Dev 9, 159 – 184. doi: doi:10.5304/jafscd.2020.092.009
- de Oliveira M. C., Bruschi M. L. (2022). Self-Emulsifying Systems for Delivery of Bioactive Compounds from Natural Origin. AAPS PharmSciTech 23 (5), 134. doi:. doi:10.1208/s12249-022-02291-z
- Desai D. A., Cristofoletti R. (2025). Bench to Bedside Modeling of mRNA Encoding IgG Using a Multiscale Mechanistic Pharmacokinetic-Toxicokinetic (PK-TK) Model: A Case Study With Anti-Claudin 18.2. Clinical and Translational Science 18 (9), e70356. doi:. doi:10.1111/cts.70356
- Doğan G., Taşkın Z., Kulczycki E., Szadkowski K. (2023). How inclusive are the international conferences? Attending conferences in an unequal world. Lect. Notes Comput. Sci. 13971, 501 – 508. doi: doi:10.1007/978-3-031-28035-1_37
- Donthu N., Kumar S., Mukherjee D., Pandey N., Lim W. M. (2021). How to conduct a bibliometric analysis: An overview and guidelines. J. Business. Res. 133, 285 – 296. doi: doi:10.1016/j.jbusres.2021.04.070
- Elkayam Cohen T., Fluhr R. (2024). Everything, everywhere, and all at once: A blueprint for supra-organization of core facilities. FASEB Bioadv. 6, 519 – 525. doi: doi:10.1096/fba.2024-00094
- Febnteh E. B., Kinge T. R., Anjah M. G., Ogwu M. C. (2025). “ Diversity of pleurotus species in Cameroon and Nigeria,” in Bioactive Compounds in Edible Mushrooms: Sustainability and Health Applications (Springer Nature Switzerland, Cham), 413 – 434.
- Fell C., Mohammadi M., Morrison D., Arandjelovic O., Caie P., Harris-Birtill D. (2022). Reproducibility of deep learning in digital pathology whole slide image analysis. PLoS Digital Health 1 (12), e0000145.
- Flores G. A., Girometta C. E., Cusumano G., Pellegrino R. M., Silviani S., Bistocchi G.. (2023). Diversity of Pleurotus spp. (Agaricomycetes) and their metabolites of nutraceutical and therapeutic importance. Int. J. Med. Mushrooms. 25. doi: doi:10.1615/intjmedmushrooms.2023048295
- Garg S., Kim M., Romero-Suarez D. (2025). Current advancements in fungal engineering technologies for Sustainable Development Goals. Trends Microbiol. 33, 285 – 301. doi: doi:10.1016/j.tim.2024.11.001
- Ghafoor A., Niazi A. R. (2025). Pleurotus spp: An ultimate solution to the emerging calamities of the world. N. Z. J. Bot. 63, 1770 – 1807. doi: doi:10.1080/0028825X.2024.2387185
- Gómez-Jiménez M.Á., Manzano-Gómez L. A., Rincón-Molina C. I., Gen-Jiménez A., Salvador-Morales P., Rincón-Molina F. A.. (2026). Agrobiotechnological potential of Pleurotus ostreatus from an ecological–socioeconomic perspective in Mexico. Sustainability 18, 6. doi: doi:10.3390/su18010006
- Govindaraj S., Renganathan S. (2017). Molecular Characterization and Phytochemical Studies of Pleurotus sp to Unveil Species Diversity and Pharmacological Activities. Journal of Pure & Applied Microbiology 11 (2).
- Gregori A., Švagelj M., Pohleven J. (2007). Cultivation techniques and medicinal properties of Pleurotus spp. Food. Technol. Biotechnol. 45, 238 – 249.
- He X.-L., Li Q., Peng W.-H., Zhou J., Cao X.-L., Wang D.. (2017). Intra- and inter-isolate variation of ribosomal and protein-coding genes in Pleurotus: Implications for molecular identification and phylogeny on fungal groups. BMC Microbiol. 17, Article 139. doi: doi:10.1186/s12866-017-1046-y
- He C., Wu J., Zhang Q. (2020). Research leadership flow determinants and the role of proximity in research collaborations. J. Assoc. Inf. Sci. Technol. 71, 1341 – 1356. doi: doi:10.1002/asi.24331
- He C., Wu J., Zhang Q. (2021). Characterizing research leadership on geographically weighted collaboration network. Scientometrics 126, 4005 – 4037. doi: doi:10.1007/s11192-021-03943-w
- Ioannidis J. P. A. (2019). Reproducible pharmacokinetics. Journal of Pharmacokinetics and Pharmacodynamics 46 (2), 111 – 116. doi:. doi:10.1007/s10928-019-09621-y
- Jayakumar T., Thomas P. A., Geraldine P. (2009). In-vitro antioxidant activities of an ethanolic extract of the oyster mushroom, Pleurotus ostreatus. Innovative. Food. Sci. Emerg. Technol. 10, 228 – 234. doi: doi:10.1016/j.ifset.2008.07.002
- Kanwal F., Amos C. I., Sippel K. H., Neuhauser C., Harrison A., Dickinson M. E.. (2025). A Survey Study of Roadblocks in Translational Science. Clinical and Translational Science 18 (7), e70259. doi:. doi:10.1111/cts.70259
- Karakhanova L., Makhmudova D., Shernazarov I., Khujanov E. (2024). Biotechnology breakthroughs: Shaping the future of health, agriculture, and industry. Bio Web Conferences. 141, 4003. doi: doi:10.1051/bioconf/202414104003
- Karp N. A. (2018). Reproducible preclinical research—Is embracing variability the answer ? PLoS Biology 16 (3), e2005413.
- Khatua S. (2025). “ Immunostimulatory potential of Pleurotus spp.: Mechanisms and applications,” in Pleurotus: From Farm to Pharmacy (CRC Press), 143 – 156. doi: doi:10.1201/9781003527572-10
- Klincewicz K., Esmaeil Zaei M. (2025). The effects of investments in research infrastructures of higher education institutes: Evidence from Poland and Czechia. Res. Policy 54, 105338. doi: doi:10.1016/j.respol.2025.105338
- Koch S., Tetley C., Strelnyk O., Sunagawa S., Boshoff N., Uisso A. J.. (2025). Reproducing inequality: Collaboration habitus and its epistemic implications in African-European research projects on forests. Minerva. 64 (1), 241 – 264. doi: doi:10.1007/s11024-025-09570-6
- Konur O. (2020). “ The scientometric analysis of the research on the algal structures,” in Handbook of Algal Science, Technology and Medicine (Academic Press), 41 – 60.
- Lems W. F., Anastasilakis A. D., Andreasen C. M., Paccou J., Rolvien T., Tencerova M.. (2025). Basic and Clinical Scientists Working Together—Do We Make the Best of Both Worlds ? Calcified Tissue International 116 (1), 39. doi:. doi:10.1007/s00223-025-01347-z
- Letourneur D., Joyce K., Chauvierre C., Bayon Y., Pandit A. (2021). Enabling MedTech Translation in Academia: Redefining Value Proposition with Updated Regulations. Advanced Healthcare Materials 10 (1), e2001237. doi:. doi:10.1002/adhm.202001237
- Li J., Bau T., Yang Z. (2022). Review on the origin, evolution and species delimitation of Pleurotus. J. Fungal Res. 20, 235 – 245. doi: doi:10.13341/j.jfr.2022.1563
- Li J., He X., Liu X.-B., Yang Z. L., Zhao Z.-W. (2017). Species clarification of oyster mushrooms in China and their DNA barcoding. Mycol. Prog. 16, 191 – 203. doi: doi:10.1007/s11557-016-1266-9
- Lindequist U., Niedermeyer T. H., Jülich W. D. (2005). The pharmacological potential of mushrooms. Evidence‐Based. Complementary. Altern. Med. 2, 285 – 299. doi: doi:10.1093/ecam/neh107
- Lippi G., Bassi A., Bovo C. (2016). The future of laboratory medicine in the era of precision medicine. Journal of Laboratory and Precision Medicine 1 (3).
- Liu C., Gui Q., Duan D., Yin M. (2017). Structural heterogeneity and proximity mechanism of global scientific collaboration network based on co-authored papers. Dili. Xuebao/Acta. Geographica. Sin. 72, 737 – 752. doi: doi:10.11821/dlxb201704014
- Lozada-Martinez L. M., Reyes-Duque J. D., Marin-Hamburger Y., Lozada-Martinez I. D. (2026). Pleurotus ostreatus for environmental remediation and sustainable bioprocesses: An evidence-mapped review of research gaps and opportunities. J. Fungi. 12, 54. doi: doi:10.3390/jof12010054
- Marshall J. C., Deitch E., Moldawer L. L., Opal S., Redl H., van der Poll T. (2005). Preclinical models of shock and sepsis: what can they tell us ? Shock 24, 1 – 6.
- Mastranzo-Pérez L. A., Hernández-Domínguez E. M., Falcón-León M. P., Álvarez-Cervantes J. (2025). Pleurotus spp: A cosmopolitan fungi of biotechnological importance. Sci. Agropecuaria. 16, 79 – 91. doi: doi:10.17268/sci.agropecu.2025.008
- Mazumdar S., Faruque M. O., Islam T., Amin M. R., Rakib M. A., Alauddin M. (2025). Exploring natural AMPK activators from bioactive compounds in fenugreek and oyster mushroom for management of type 2 diabetes. Scientific Reports 15 (1), 44591. doi:. doi:10.1038/s41598-025-28349-z
- Meisner J., McLeland-Wieser H., Traylor E. E., Hermesh B., Berg T., Roess A.. (2024). Relational One Health: A more-than-biomedical framework for more-than-human health, and lessons learned from Brazil, Ethiopia, and Israel. One Health 18, 100676. doi: doi:10.1016/j.onehlt.2024.100676
- Morenikeji Abel O., Elijah Adegoke A., Nathaniel Aanu A., Oluwaseun Adepeju O., Busayo Mutiat O. (2025). “ Global market prospects and opportunities for oyster mushrooms,” in Pleurotus: From Farm to Pharmacy (CRC Press), 195 – 210. doi: doi:10.1201/9781003527572-14
- Nowbuth A. A., Parmar V. S. (2025). Design framework to develop sustainable innovations for addressing One Health challenges. One Health 20, 101031. doi: doi:10.1016/j.onehlt.2025.101031
- Obajemu A. S., Ekere F. C., Ezeani C. N. (2012). The Nigerian Postgraduate Medical Journal 1999 to 2008: a scientometric appraisal. Nigerian. Q. J. Hosp. Med. 22, 249 – 257.
- Palmieri G., Cennamo G., Sannia G. (2005). Remazol Brilliant Blue R decolourisation by the fungus Pleurotus ostreatus and its oxidative enzymatic system. Enzyme Microb. Technol. 36, 17 – 24. doi: doi:10.1016/j.enzmictec.2004.03.026
- Patel S., Rauf A., Khan H., Khalid S., Mubarak M. S. (2017). Potential health benefits of natural products derived from truffles: A review. Trends in Food Science & Technology 70, 1 – 8.
- Phonemany M., Raspé O., Sysouphanthong P., Niego A. G., Niego T., Thongklang N.. (2021). Two Pleurotus species (Pleurotaceae) from lao people’s democratic republic. Chiang. Mai. J. Sci. 48, 1224 – 1235.
- Pumipuntu N., Suwannarong K. (2025). “ Collaborations and challenges between medical and veterinary professionals in One Health implementation,” in Drug Discovery and One Health Approach in Combating Infectious Diseases: A Multi-Sectoral Approach to Address Infections (Elsevier), 303 – 322. doi: doi:10.1016/B978-0-443-27461-9.00018-4
- Raman J., Jang K. Y., Oh Y. L., Oh M., Im J. H., Lakshmanan H.. (2021). Cultivation and nutritional value of prominent Pleurotus spp.: an overview. Mycobiology 49, 1 – 14. doi: doi:10.1080/12298093.2020.1835142
- Rathore H., Prasad S., Sharma S. (2017). Mushroom nutraceuticals for improved nutrition and better human health: A review. PharmaNutrition 5, 35 – 46. doi: doi:10.1016/j.phanu.2017.02.001
- Reis F. S., Martins A., Barros L., Ferreira I. C. (2012). Antioxidant properties and phenolic profile of the most widely appreciated cultivated mushrooms: A comparative study between in vivo and in vitro samples. Food Chem. Toxicol. 50, 1201 – 1207. doi: doi:10.1016/j.fct.2012.02.013
- Roberts C. B., Browne R., Wilson T. E., Rashied-Henry K., Primus N., Shaw R.. (2012). “ Lessons learned from building an infrastructure for community-engaged research,” in Building Community Capacity: Skills and Principles (Nova Science Publishers), 23 – 34. Available online at: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060556204.
- Roch C., Klein S. G., Angulo-Preckler C., Hutahaean A. A., Wambugu J., Yranzo-Duque A.. (2025). Towards inclusive global collaborations in coral reef science. NPJ Ocean. Sustain. 4, 16. doi: doi:10.1038/s44183-025-00120-x
- Ruwizhi N., Aderibigbe B. A. (2020). Cinnamic acid derivatives and their biological efficacy. Int. J. Mol. Sci. 21, 5712. doi: doi:10.3390/ijms21165712
- Sarangi I., Ghosh D., Bhutia S. K., Mallick S. K., Maiti T. K. (2006). Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans. Int. Immunopharmacol. 6, 1287 – 1297. doi: doi:10.1016/j.intimp.2006.04.002
- Schein D., Escosteguy O. C., Pezzini G. N., Wancura J. H. C., Mazutti M. A. (2026). Technology readiness level assessment of Pleurotus spp. enzymes for lignocellulosic biomass deconstruction. Processes 14, 112. doi: doi:10.3390/pr14010112
- Selvaananthi A., Beulah Jerlin S. (2024). Bioactive components and therapeutic potential of Pleurotus florida: A comprehensive analysis. Biologica Nyssana 15 (2), 135 – 144. doi:. doi:10.5281/zenodo.13944287
- Sharma A., Jandaik S., Thakur N. (2020). Comparison of yield, nutrient content and antibacterial activities of wild and cultivated isolates of Pleurotus djamor. Agric. Sci. Digest. 40, 280 – 284. doi: doi:10.18805/ag.D-5099
- Silva M., Ramos A. C., Lidon F. J., Reboredo F. H., Gonçalves E. M. (2024). Pre- and postharvest strategies for Pleurotus ostreatus mushroom in a circular economy approach. Foods 13, 1464. doi: doi:10.3390/foods13101464
- Singh J., Kumar P., Kumar A. (2025). Global disparities and data transparency in editorial boards of prominent internal medicine journals including allied super specialties: A wake-up call. Indian J. Med. Ethics. 10, 278 – 287. doi: doi:10.20529/IJME.2025.045
- Stegemann S., Leveiller F., Franchi D., de Jong H., Linden H. (2007). When poor solubility becomes an issue: from early stage to proof of concept. European Journal of Pharmaceutical Sciences 31 (5), 249 – 261. doi:. doi:10.1016/j.ejps.2007.05.110
- Sullivan R., Smith J. E., Rowan N. J. (2006). Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine. Perspect. Biol. Med. 49, 159 – 170. doi: doi:10.1353/pbm.2006.0034
- Tolochko P., Vadrot A. B. M. (2021). The usual suspects? Distribution of collaboration capital in marine biodiversity research. Mar. Policy 124, 104318. doi: doi:10.1016/j.marpol.2020.104318
- Utomo B. (2026). “ Connection of human, animal, and environmental health: A One Health perspective,” in One Health Integration: Global Perspectives on Animal Health and Sustainable Agriculture (Wiley), 63 – 80. doi: doi:10.1002/9781394295982.ch03
- Valdez J., Damasceno G., Oh R. R. Y., Quintero Uribe L. C., Barajas Barbosa M. P., Amado T. F.. (2024). Strategies for advancing inclusive biodiversity research through equitable practices and collective responsibility. Conserv. Biol. 38, e14325. doi: doi:10.1111/cobi.14325
- Wang C., Wang L. (2024). Adaptive weight learning for multiple outcome optimization with continuous treatment (arXiv:2402.11092). arXiv. doi:. doi:10.48550/arXiv.2402.11092
- Xie P., Ye Y. H., Wang C. Q., Shen J. H., Chen L. H., Zhang Y. N. (2024). A hybrid RSM-BPNN-GA approach for optimizing ultrasound-assisted deep eutectic solvents extraction conditions for Mesona chinensis Benth. and investigation of the extraction mechanism. Journal of Food Science 89 (9), 5531 – 5546.
- Yang X., Xu Y., Huo H. (2025). Optimization of flavonoids from Astragalus membranaceus stem and leaf waste using nonionic surfactant-integrated ultrasound-assisted extraction. Ultrasonics Sonochemistry, 107606.
- Yao X., Kanellakis N. I. (2020). In vitro and in vivo laboratory models. In: Pleural Disease. Sheffield: ERS, 29 – 47.
- You Q., Ren Y., Li J., Zeng G., Luo X., Zheng C., Tang Z. (2025). Ultrasound-assisted enzymatic extraction of the active components from Acanthopanax sessiliflorus stem and bioactivity comparison with Acanthopanax senticosus. Molecules 30 (2), 397.
- Zhang C. J., Guo J. Y., Cheng H., Lin L., Liu Y., Shi Y.. (2020). Protective effects of the king oyster culinary-medicinal mushroom, Pleurotus eryngii (Agaricomycetes), polysaccharides on β-amyloid-induced neurotoxicity in PC12 cells and aging rats, in vitro and in vivo studies. International Journal of Medicinal Mushrooms 22 (4), 325 – 333. doi:. doi:10.1615/IntJMedMushrooms.2020033990
- Zhang M., Zhang S., Wang L., Zhang Z., Hu Q., Liu D. (2024). Key factors for improving predictive accuracy and avoiding overparameterization of the PBPK absorption model in food effect studies of weakly basic water-insoluble compounds in immediate release formulations. Pharmaceutics 16 (10), 1324.
- Zervakis G. I. (2004). The necessity to exploit multifaceted approaches for resolving the systematics in Basidiomycotina: Case studies on edible mushrooms. Ital. Bot. 36, 251 – 256.
Citation
Cabuhat, K. S. P., et al. (2026). Global trends, translational gaps, and emerging research directions in Pleurotus spp. bioactivity research: a 25-year scientometric analysis. Frontiers in Fungal Biology, Volume 7. https://doi.org/
- Received
- Accepted
- Published
- Volume
- 7 - 2026
Copyright
Copyright © 2026 Cabuhat, Fortaleza, Cabalbag, Ong, Cruz, del Rosario, Lee, Nuevo, Matamis, Mamaat, Libres and Dulay.
License: https://creativecommons.org/licenses/by/4.0/
*Correspondence: Jamil Allen G. Fortaleza
Article metrics
- Views
- 0
- Downloads
- 0
- Citations
- 0
- Shares
- 0
